Form 4: Cardlytics Director Jonathan Edward Francis Reports Stock Transactions

Director Jonathan Edward Francis reports the vesting and conversion of restricted stock units into common stock.

Summary

• On May 23, 2025, Jonathan Edward Francis, a director of Cardlytics, Inc., reported a transaction involving restricted stock units.
• 11,000 restricted stock units vested and were converted into 11,000 shares of common stock.
• The transaction was executed on May 23, 2025.
• Following the transaction, Francis directly owns 15,310 shares of Cardlytics common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares, but it is unlikely to be significant.

Key Dates

Keywords

Cardlytics, Director, Stock, Transaction, RSU, CDLX, Vesting